Evidence map›Paper›PMID 37290907›Full record

ArticleJournal of medical genetics2023

The Phenotypic variability of 16p11.2 distal BP2-BP3 deletion in a transgenerational family and in neurodevelopmentally ascertained samples.

Marc Woodbury-Smith, Lia D'Abate, Dimitri J Stavropoulos, Jennifer Howe, Irene Drmic, Ny Hoang, Mehdi Zarrei, Brett Trost, Alana Iaboni, Evdokia Anagnostou and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medical genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Marc Woodbury-Smith *The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada marc.woodbury-smith@newcastle.ac.uk.ORCID 0000-0002-0593-8917
Lia D'Abate *The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Dimitri J StavropoulosThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Jennifer HoweThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Irene DrmicThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Ny HoangDepartment of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.
Mehdi ZarreiThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Brett TrostThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.ORCID 0000-0003-4863-7273
Alana IaboniAutism Research Centre, Holland Bloorview Kids Rehabilitation Centre, Toronto, Ontario, Canada.
Evdokia AnagnostouAutism Research Centre, Holland Bloorview Kids Rehabilitation Centre, Toronto, Ontario, Canada.
Stephen W SchererThe Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Hospital for Sick Children · CAUniversity of Toronto · CAHolland Bloorview Kids Rehabilitation Hospital · CA

Funding

Subject CollectionU10AA008401 · NIAAA · SUNY DOWNSTATE MEDICAL CENTER · PI JESSICA E SALVATORE · 1989 to 2026
$162.7M
JH/CIDR Genotyping for Genome-Wide Association StudiesU01HG004438 · NHGRI · JOHNS HOPKINS UNIVERSITY · PI VALLE, DAVID · 2007 to 2011
$24.2M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2001 to 2012
$17.3M
RELAPSE: LINKING SCIENCE AND PRACTICEP50CA084724 · NCI · UNIVERSITY OF WISCONSIN MADISON · PI FIORE, MICHAEL C · 1999 to 2003
$8.9M
Tobacco Dependence: Treatment and OutcomesP50DA019706 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI JACKSON, THOMAS C · 2004 to 2008
$8.6M
Genome Wide Association Coordinating CenterU01HG004446 · NHGRI · UNIVERSITY OF WASHINGTON · PI WEIR, BRUCE S. · 2007 to 2011
$6.6M
FAMILY STUDY OF COCAINE DEPENDENCER01DA013423 · NIDA · WASHINGTON UNIVERSITY · PI BIERUT, LAURA JEAN · 2000 to 2004
$2.2M
Study of Addiction: Genetics and EnvironmentU01HG004422 · NHGRI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2007 to 2010
$1.2M
NCI NIH HHS P01 CA089392NCI NIH HHS P50 CA084724NHGRI NIH HHS HHSN268200782096CNHGRI NIH HHS U01 HG004422NHGRI NIH HHS U01 HG004438NHGRI NIH HHS U01 HG004446NIAAA NIH HHS U10 AA008401NIDA NIH HHS P50 DA019706NIDA NIH HHS R01 DA013423
6 · The paper itself

Abstract

backgroundWe present genomic and phenotypic findings of a transgenerational family consisting of three male offspring, each with a maternally inherited distal 220 kb deletion at locus 16p11.2 (BP2-BP3). Genomic analysis of all family members was prompted by a diagnosis of autism spectrum disorder (ASD) in the eldest child, who also presented with a low body mass index.

methodsAll male offspring underwent extensive neuropsychiatric evaluation. Both parents were also assessed for social functioning and cognition. The family underwent whole-genome sequencing. Further data curation was undertaken from samples ascertained for neurodevelopmental disorders and congenital abnormalities.

resultsOn medical examination, both the second and third-born male offspring presented with obesity. The second-born male offspring met research diagnostic criteria for ASD at 8 years of age and presented with mild attention deficits. The third-born male offspring was only noted as having motor deficits and received a diagnosis of developmental coordination disorder. Other than the 16p11.2 distal deletion, no additional contributing variants of clinical significance were observed. The mother was clinically evaluated and noted as having a broader autism phenotype.

conclusionIn this family, the phenotypes observed are most likely caused by the 16p11.2 distal deletion. The lack of other overt pathogenic mutations identified by genomic sequencing reinforces the variable expressivity that should be heeded in a clinical setting. Importantly, distal 16p11.2 deletions can present with a highly variable phenotype even within a single family. Our additional data curation provides further evidence on the variable clinical presentation among those with pathogenetic 16p11.2 (BP2-BP3) mutations.

Indexed as

Autism Spectrum DisorderAutistic DisorderIntellectual DisabilityBiological Variation, PopulationChildChromosome DeletionChromosomes, Human, Pair 16FamilyHumansMalePhenotypeGenomicsPhenotypePsychiatry

Identifiers

PMID37290907
PMCPMC10715508
OpenAlexW4379876264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.